HumanMAP Services

Identification of biomarker patterns in a biological sample, such as serum or plasma, can dramatically increase the success of almost any drug development program. RBM's MAP approach provides investigators with a validated, reliable platform that allows discovery, validation, and clinical use of these patterns in a cost-effective, efficient manner.

Services

RBM's Human MAPs represent the most comprehensive menu of quantitative, multiplexed immunoassays commercially available. Our Human MAPs provides insight into multiple pathways to help better understand the underlying biology.

Please click on the following MAPs for a complete list of included analytes.

Human Sample Volume Requirements
MAP Volume Required
Serum or plasma Other fluids*
Human DiscoveryMAP™ v. 1.0 500 µL N/A
HumanMAP® v. 1.6 Antigens 100 µL 350 µL
Human PsyMAP™ v. 1.0 120 µL ** 600 µL
Human CardiovascularMAP™ v. 1.0 100 µL 350 µL
Human InflammationMAP™ v. 1.0 100 µL 200 µL
Human KidneyMAP™ v. 1.0 100 µL 350 µL
Human MetabolicMAP™ v. 1.0 100 µL 350 µL
Human TruCulture™ MAP v. 1.1 100 µL 200 µL (TruCulture™ Supernatant)
Human Human CytokineMAP™ A v. 1.0 50 µL 100 µL
Human Human CytokineMAP™ B v.1.0 50 µL 100 µL
Human Autoimmune SerologyMAP™ v. 1.0 40 µL N/A
Human Infectious Disease SerologyMAP v. 1.0 40 µL N/A

Quality

RBM is a CLIA certified laboratory that supports GLP studies. All testing is performed to the highest standards of scientific quality in accordance with our standard operating procedures and applicable regulatory requirements.

Please click here to read more about our laboratory's quality standards and MAP validation process.